- call +1-201-465-4211
- email sales@mrinsights.biz
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Scope of the Report:
The worldwide market for Human Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Human Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Other
Market Segment by Applications, can be divided into
Adults
Children
There are 15 Chapters to deeply display the global Human Vaccines market.
Chapter 1, to describe Human Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Vaccines, with sales, revenue, and price of Human Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Human Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Varicella
1.2.2 Influenza
1.2.3 Polio
1.2.4 Hepatitis A
1.2.5 Rabies
1.2.6 BCG
1.2.7 Hepatitis B
1.2.8 Other
1.3 Market Analysis by Applications
1.3.1 Adults
1.3.2 Children
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CNBG
2.1.1 Business Overview
2.1.2 Human Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CNBG Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Changsheng Life
2.2.1 Business Overview
2.2.2 Human Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Changsheng Life Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Zhifei
2.3.1 Business Overview
2.3.2 Human Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Zhifei Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 ChengDa Bio
2.4.1 Business Overview
2.4.2 Human Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 ChengDa Bio Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Kangtai
2.5.1 Business Overview
2.5.2 Human Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Kangtai Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 SINOVAC BIOTECH
2.6.1 Business Overview
2.6.2 Human Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 SINOVAC BIOTECH Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hissen
2.7.1 Business Overview
2.7.2 Human Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hissen Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Walvax Biotechnology
2.8.1 Business Overview
2.8.2 Human Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Walvax Biotechnology Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 GSK
2.9.1 Business Overview
2.9.2 Human Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GSK Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 SANOFI
2.10.1 Business Overview
2.10.2 Human Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 SANOFI Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Rong An
2.11.1 Business Overview
2.11.2 Human Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Rong An Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 NuoCheng Bio
2.12.1 Business Overview
2.12.2 Human Vaccines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 NuoCheng Bio Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Hualan Bio
2.13.1 Business Overview
2.13.2 Human Vaccines Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Hualan Bio Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Tiantan biological
2.14.1 Business Overview
2.14.2 Human Vaccines Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Tiantan biological Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Changchun Baike
2.15.1 Business Overview
2.15.2 Human Vaccines Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Changchun Baike Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Adimmune
2.16.1 Business Overview
2.16.2 Human Vaccines Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Adimmune Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Zhongyianke Biotech
2.17.1 Business Overview
2.17.2 Human Vaccines Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Zhongyianke Biotech Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Human Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 Human Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Human Vaccines Market Analysis by Regions
4.1 Global Human Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Human Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global Human Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America Human Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe Human Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Vaccines Sales and Growth Rate (2013-2018)
4.5 South America Human Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Vaccines Sales and Growth Rate (2013-2018)
5 North America Human Vaccines by Countries
5.1 North America Human Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America Human Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America Human Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States Human Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada Human Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico Human Vaccines Sales and Growth Rate (2013-2018)
6 Europe Human Vaccines by Countries
6.1 Europe Human Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe Human Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Human Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany Human Vaccines Sales and Growth Rate (2013-2018)
6.3 UK Human Vaccines Sales and Growth Rate (2013-2018)
6.4 France Human Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia Human Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy Human Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific Human Vaccines by Countries
7.1 Asia-Pacific Human Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Human Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Human Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China Human Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan Human Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea Human Vaccines Sales and Growth Rate (2013-2018)
7.5 India Human Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Human Vaccines Sales and Growth Rate (2013-2018)
8 South America Human Vaccines by Countries
8.1 South America Human Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America Human Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America Human Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Human Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina Human Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia Human Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa Human Vaccines by Countries
9.1 Middle East and Africa Human Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Human Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Human Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE Human Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt Human Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria Human Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa Human Vaccines Sales and Growth Rate (2013-2018)
10 Global Human Vaccines Market Segment by Type
10.1 Global Human Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Human Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global Human Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Varicella Sales Growth and Price
10.2.1 Global Varicella Sales Growth (2013-2018)
10.2.2 Global Varicella Price (2013-2018)
10.3 Influenza Sales Growth and Price
10.3.1 Global Influenza Sales Growth (2013-2018)
10.3.2 Global Influenza Price (2013-2018)
10.4 Polio Sales Growth and Price
10.4.1 Global Polio Sales Growth (2013-2018)
10.4.2 Global Polio Price (2013-2018)
10.5 Hepatitis A Sales Growth and Price
10.5.1 Global Hepatitis A Sales Growth (2013-2018)
10.5.2 Global Hepatitis A Price (2013-2018)
10.6 Rabies Sales Growth and Price
10.6.1 Global Rabies Sales Growth (2013-2018)
10.6.2 Global Rabies Price (2013-2018)
10.7 BCG Sales Growth and Price
10.7.1 Global BCG Sales Growth (2013-2018)
10.7.2 Global BCG Price (2013-2018)
10.8 Hepatitis B Sales Growth and Price
10.8.1 Global Hepatitis B Sales Growth (2013-2018)
10.8.2 Global Hepatitis B Price (2013-2018)
10.9 Other Sales Growth and Price
10.9.1 Global Other Sales Growth (2013-2018)
10.9.2 Global Other Price (2013-2018)
11 Global Human Vaccines Market Segment by Application
11.1 Global Human Vaccines Sales Market Share by Application (2013-2018)
11.2 Adults Sales Growth (2013-2018)
11.3 Children Sales Growth (2013-2018)
12 Human Vaccines Market Forecast (2018-2023)
12.1 Global Human Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 Human Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America Human Vaccines Market Forecast (2018-2023)
12.2.2 Europe Human Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific Human Vaccines Market Forecast (2018-2023)
12.2.4 South America Human Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa Human Vaccines Market Forecast (2018-2023)
12.3 Human Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global Human Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global Human Vaccines Market Share Forecast by Type (2018-2023)
12.4 Human Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global Human Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global Human Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Human Vaccines Picture
Table Product Specifications of Human Vaccines
Figure Global Sales Market Share of Human Vaccines by Types in 2017
Table Human Va
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
